Italian pharmaceuticals Rottapharm Madaus this week sold itself in a $3.1 billion deal without appointing an investment bank to the mandate, a move one City of London healthcare banker described as "scary".

Swedish pharma company Meda yesterday agreed the deal to acquire Rottapharm, which is owned by the Rovati family.